Biocon rises on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Biocon is currently trading at Rs. 273.70, up by 4.10 points or 1.52% from its previous closing of Rs. 269.60 on the BSE.
The scrip opened at Rs. 272.95 and has touched a high and low of Rs. 276.85 and Rs. 270.20 respectively. So far 88814 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 410.50 on 08-Feb-2022 and a 52 week low of Rs. 258.30 on 17-Oct-2022.
Last one week high and low of the scrip stood at Rs. 276.85 and Rs. 259.25 respectively. The current market cap of the company is Rs. 33142.56 crore.
The promoters holding in the company stood at 60.64%, while Institutions and Non-Institutions held 23.55% and 15.81% respectively.
Biocon’s subsidiary -- Biocon Biologics has been recognized as a Company with Great Managers at the Great Manager Awards (GMA) 2022. Biocon Biologics is among the Top 50 Companies among 175 participating companies to feature on this prestigious list.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
